Di Croce Lab
Gene Regulation, Stem Cells and Cancer
- Group page
- Research lines
- Group members
- Publications at CRG
1996 PhD Dept. Cellular and Developmental Biology, University of Rome, Italy.
1996-2000 Postdoctoral work at the University of Marburg, Germany.
2000-2002 Senior Investigator at the European Institute of Oncology, Milan, Italy.
2003 ICREA Research Professor and Group Leader at the Centre de Regulació Genòmica(CRG), Barcelona, Spain.
Training the next generation of scientists in three-dimensional architecture of the genome (08/11/2018)
ChromDesign is a new European training network recruiting now 13 PhD candidates (Early Stage Researchers. ChromDesign PhD fellows will investigate how the genome organizes in 3D over time and its relationship to gene regulation in health and disease.
Take my hand and ride with me - over the genome (01/10/2018)
Researchers at the Centre for Genomic Regulation (CRG) in Barcelona, Spain, have identified the mechanism by which an important enzyme involved in the differentiation of stem cells is brought to the DNA.
When a chemical tag makes the difference in cell fate and gene expression (18/09/2018)
Scientists at the Centre for Genomic Regulation in Barcelona, Spain, have uncovered the role of special chemical ‘tags’ in controlling vital genes involved in early mammalian development, publishing their findings in the journal Nature Genetics on 17thSeptember.
Two proteins safeguard skin stem cells (28/07/2016)
Without these proteins, skin stem cells are lost. The study headed by CRG Alumnus Salvador Aznar Benitah at IRB Barcelona has been published today in Cell Stem Cell.
Understanding the genetic basis of cancers has been a topic of intense research, and hundreds of gene mutations have been identified that can cause carcinogenesis. However, in the past few years, increasing evidence has suggested that mutations are not the only genetic changes that lead to cancer. Indeed, perturbations of chromatin structure and of other epigenetic mechanisms can cause inappropriate gene expression and genomic instability, resulting in cellular transformation and malignant outgrowth.
Our research investigation is focused on understanding the role of several protein complexes that are involved in chromatin dynamics and metabolism, which when altered could participate in the establishment and maintenance of the aberrant silencing of tumor suppressor genes during transformation. Our results suggested that the Nucleosome Remodelling and Deacetylase complex (NuRD), Polycomb group of proteins (PcG) and the histone variant macroH2A are - with different timing and kinetics - involved in setting up an altered chromatin structure with aberrant gene silencing in acute promyelocytic leukemia (APL). We believe that the results of our research will lead to the identification of new biological tools with a potential impact on cancer therapeutic intervention.